| Primary |
| Gout |
18.0% |
| Patent Ductus Arteriosus |
15.6% |
| Product Used For Unknown Indication |
10.5% |
| Pain |
9.7% |
| Drug Exposure During Pregnancy |
5.4% |
| Drug Use For Unknown Indication |
3.8% |
| Ankylosing Spondylitis |
3.5% |
| Rheumatoid Arthritis |
3.5% |
| Extradural Abscess |
3.2% |
| Headache |
3.2% |
| Back Pain |
3.0% |
| Psoriatic Arthropathy |
3.0% |
| Arthralgia |
2.7% |
| Spondylitis |
2.7% |
| Arthritis |
2.4% |
| Adjustment Disorder |
2.2% |
| Osteoarthritis |
2.2% |
| Hiv Infection |
1.9% |
| Juvenile Arthritis |
1.9% |
| Tocolysis |
1.9% |
|
| Renal Failure Acute |
14.6% |
| Vomiting |
12.3% |
| Thrombocytopenia |
9.2% |
| Sepsis Neonatal |
8.5% |
| Nausea |
5.4% |
| Renal Impairment |
5.4% |
| Gastrointestinal Haemorrhage |
3.8% |
| Peritonitis |
3.8% |
| Periventricular Leukomalacia |
3.8% |
| Thrombosis |
3.8% |
| Tremor |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Intestinal Perforation |
3.1% |
| Maternal Drugs Affecting Foetus |
3.1% |
| Syncope |
3.1% |
| Upper Gastrointestinal Haemorrhage |
3.1% |
| Death |
2.3% |
| Drug Eruption |
2.3% |
| Drug Interaction |
2.3% |
| Intraventricular Haemorrhage |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
28.6% |
| Drug Use For Unknown Indication |
22.7% |
| Headache |
9.0% |
| Bone Disorder |
4.1% |
| Hiv Infection |
4.1% |
| Respiratory Disorder |
4.1% |
| Gout |
3.8% |
| Rheumatoid Arthritis |
3.1% |
| Hypertension |
2.4% |
| Pain |
2.4% |
| Migraine |
2.2% |
| Juvenile Arthritis |
1.9% |
| Hyperemesis Gravidarum |
1.8% |
| Osteoarthritis |
1.7% |
| Folliculitis |
1.6% |
| Ankylosing Spondylitis |
1.4% |
| Asthma |
1.3% |
| Back Pain |
1.3% |
| Bone Pain |
1.2% |
| Thrombosis Prophylaxis |
1.1% |
|
| Renal Failure Acute |
15.5% |
| Vomiting |
10.4% |
| Completed Suicide |
7.8% |
| Drug Hypersensitivity |
6.2% |
| Necrotising Colitis |
6.2% |
| Urinary Tract Infection |
6.2% |
| Premature Baby |
5.2% |
| Renal Tubular Necrosis |
5.2% |
| Rash |
4.7% |
| Renal Failure |
4.1% |
| Weight Decreased |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Pain In Jaw |
3.1% |
| Urticaria |
3.1% |
| Rash Morbilliform |
2.6% |
| Syncope |
2.6% |
| Thrombocytopenia |
2.6% |
| Toxicity To Various Agents |
2.6% |
| Urinary Retention |
2.6% |
| Atrial Fibrillation |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.3% |
| Rheumatoid Arthritis |
17.5% |
| Product Used For Unknown Indication |
17.3% |
| Hypertension |
5.9% |
| Pain |
5.7% |
| Ankylosing Spondylitis |
4.7% |
| Gout |
3.1% |
| Juvenile Arthritis |
2.8% |
| Depression |
2.5% |
| Psoriatic Arthropathy |
2.4% |
| Prophylaxis |
2.4% |
| Insomnia |
1.6% |
| Osteoporosis |
1.6% |
| Multiple Myeloma |
1.5% |
| Arthritis |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Diabetes Mellitus |
1.3% |
| Anxiety |
1.3% |
| Hiv Infection |
1.2% |
| Psoriasis |
1.1% |
|
| Vomiting |
13.7% |
| Weight Decreased |
8.7% |
| Pain |
6.2% |
| Renal Failure |
5.4% |
| Pneumonia |
5.0% |
| Pulmonary Embolism |
5.0% |
| Sepsis |
5.0% |
| Pyrexia |
4.7% |
| Myocardial Infarction |
4.5% |
| Type 2 Diabetes Mellitus |
4.3% |
| Urinary Tract Infection |
4.3% |
| Weight Increased |
4.2% |
| Renal Failure Acute |
4.0% |
| Nausea |
3.8% |
| Pain In Extremity |
3.8% |
| Tremor |
3.7% |
| White Blood Cell Count Decreased |
3.5% |
| Drug Ineffective |
3.3% |
| Injection Site Pain |
3.3% |
| Oedema Peripheral |
3.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
25.5% |
| Hiv Infection |
14.9% |
| Product Used For Unknown Indication |
14.9% |
| Injury |
10.6% |
| Rheumatoid Arthritis |
8.5% |
| Depression |
6.4% |
| Urinary Tract Infection |
6.4% |
| Gout |
4.3% |
| Musculoskeletal Pain |
4.3% |
| Cardiac Valve Prosthesis User |
2.1% |
| Smoking Cessation Therapy |
2.1% |
|
| Acute Prerenal Failure |
25.0% |
| Drug Interaction |
18.8% |
| Urinary Tract Infection |
12.5% |
| Vomiting |
12.5% |
| Gastrointestinal Haemorrhage |
6.3% |
| Headache |
6.3% |
| Insomnia |
6.3% |
| Renal Failure Acute |
6.3% |
| Renal Impairment |
6.3% |
|
